MedTrace Logo

To Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent

NCT03089450 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2017-03-28

No results posted yet for this study

Summary

to evaluate safety and efficacy of CGBIO stent(DES) compared to Biomatrix flex stent(DES)

Conditions

  • Ischemic Heart Disease
  • Stable Coronary Artery Disease
  • Stable Angina
  • Unstable Angina
  • NSTEMI - Non-ST Segment Elevation MI

Interventions

DEVICE

CGBio stent

Percutaneous Coronary Intervention

DEVICE

Biomatrix flex

Percutaneous Coronary Intervention

Sponsors & Collaborators

  • CGBio Inc.

    lead INDUSTRY

Principal Investigators

  • Hyo-Soo KIim, MD/PhD · Soeoul national university hospital

  • Young-Hyo Lim, MD/PhD · Hanyang University

  • Junghan Yoon, MD/PhD · Wonju Severance Christian Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-22
Primary Completion
2017-09-30
Completion
2018-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03089450 on ClinicalTrials.gov